Generative Biology Institute
The vision of the GBI is to lay the foundations for engineering biology, and unlock its potential for good. To achieve this, we must overcome two key challenges. First, we need the ability to write in the natural language of biology, enabling the rapid and scalable synthesis of entire genomes with precision. Second, we must understand what to write, determining which DNA sequences will generate biological systems that perform the desired functions. Addressing these challenges will allow us to harness the full power of biology to create transformative solutions across health, agriculture, clean energy and more.
Part of the Ellison Institute of Technology, Oxford (“EIT”), GBI is led by founding Director Jason Chin. It will house 30 groups and more than 500 researchers at scale, focused on solving the two critical challenges in making biology engineerable and applying the solutions to addressing the global challenges encapsulated in EIT’s Humane Endeavors.
GBI will have sustained and substantial funding to support the unique scale and ambition of its ground-breaking vision for engineering biology. GBI researchers will also be supported by cutting edge facilities including mass spectrometry, flow cytometry, sequencing, automation, scientific computing, bioinformatics, and machine learning. GBI will also have access to substantial compute resources that can be leveraged to further accelerate progress. The environment at GBI will allow researchers to undertake ambitious, long-term, collaborative research, and we will actively support the translation of research to commercial applications, where appropriate.
GBI will commence operations in 2025. The team will work from a purpose-made facility in the Oxford Science Park, currently under construction. Once complete, this state-of-the-art facility will include more than 40,000 m² of research laboratory and office space.